United States · 
Who invested in Inhalon Biopharma?
Inhalon Biopharma's investors include Sand Hill Angels and Catalyst Fund.
United States · Funded startup
Who invested in Inhalon Biopharma
Funding summaryUpdated 26 Oct 2026
$2.0Mraised across 1 round since 2022, from 1 source
- Latest round
- Grant, $2.0MNov 2022
- Investors
- 2
The rounds
- Nov 2022
Founders and team
From Inhalon Biopharma's own website and the SEC filings it signed: 4 on the team.
- John B. WhelanPresident, Chief Executive Officer and Director
- Matthijs SchootsVice President, Operations
- Richard GoozhDirector
- Samuel B. LaiExecutive Officer, Directori
On the board, as filediWinnie B. Wan
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Inhalon Biopharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Inhalon Biopharma
How much has Inhalon Biopharma raised?
Inhalon Biopharma has raised $2.0M across 1 round since 2022.
When did Inhalon Biopharma last raise?
Inhalon Biopharma's most recent round was a Grant of $2.0M in Nov 2022.
What was Inhalon Biopharma's biggest round?
Its most recent round, $2.0M in Nov 2022, is also its largest on record.
Who backed Inhalon Biopharma first?
Inhalon Biopharma's first round on record, in Nov 2022, was backed by Sand Hill Angels and Catalyst Fund.
What stage is Inhalon Biopharma at?
Inhalon Biopharma's latest named round is a Grant, in Nov 2022.
Where is Inhalon Biopharma based?
Inhalon Biopharma is based in the United States.
Companies like Inhalon Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.